Responsive image

Common name


(4S)-4-[(3-methyl-1H-indol-5-yl)methyl]oxazolidin-2-one

IUPAC name


(4S)-4-[(3-methyl-1H-indol-5-yl)methyl]oxazolidin-2-one

SMILES


[nH]1c2c(c(c1)C)cc(cc2)CC3COC(=O)N3

Common name


(4S)-4-[(3-methyl-1H-indol-5-yl)methyl]oxazolidin-2-one

IUPAC name


(4S)-4-[(3-methyl-1H-indol-5-yl)methyl]oxazolidin-2-one

SMILES


[nH]1c2c(c(c1)C)cc(cc2)CC3COC(=O)N3

INCHI


InChI=1S/C13H14N2O2/c1-8-6-14-12-3-2-9(5-11(8)12)4-10-7-17-13(16)15-10/h2-3,5-6,10,14H,4,7H2,1H3,(H,15,16)/t10-/m0/s1

FORMULA


C13H14N2O2

Responsive image

Common name


(4S)-4-[(3-methyl-1H-indol-5-yl)methyl]oxazolidin-2-one

IUPAC name


(4S)-4-[(3-methyl-1H-indol-5-yl)methyl]oxazolidin-2-one





Molecular weight


230.262

clogP


2.919

clogS


-3.758

Frequency


0.0003





HBond Acceptor


2

HBond Donor


2

Total Polar
Surface Area


54.12

Number of Rings


3

Rotatable Bond


2

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD00201 Zolmitriptan Responsive image Analgesics; Serotonin Antagonists; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Anti-migraine Agents; Nervous System; Selective Serotonin (5Ht1) Agonists; Antimigraine Preparations; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; For the acute treatment of adult migraine with or without auras.
1 , 1
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
4n4v_ligand_1_1.mol2 4n4v 0.710145 -7.79 C1C(OC(=O)N1C1CCCCC1)(C)C 14
4oo9_ligand_frag_1.mol2 4oo9 0.657143 -7.62 N1([C@@H]2CCC[C@@H]([C@@H]2CC1)O)C(=O)OC 14
1xdg_ligand_4_145.mol2 1xdg 0.633803 -5.54 CN1[C@H](C[C@H](OC1=O)CC)C 11
1xdg_ligand_3_90.mol2 1xdg 0.633803 -5.50 N1[C@H](C[C@H](OC1=O)CC)C 10
4lnb_ligand_2_0.mol2 4lnb 0.615385 -6.44 O=C(OC(C)(C)C)N1CCC(CC1)C 14
2pjt_ligand_2_26.mol2 2pjt 0.615385 -5.99 CC1CCN(CC1)C(=O)OC(C)(C)C 14
4dfg_ligand_1_10.mol2 4dfg 0.604938 -6.49 N(C(=O)OC)[C@@H]1CO[C@@H]2CCC[C@H]12 13
3elm_ligand_1_6.mol2 3elm 0.6 -6.37 C(C)(C)OC(=O)N1CCCCC1 12
4lnb_ligand_1_0.mol2 4lnb 0.6 -6.30 O=C(OC(C)(C)C)N1CCCCC1 13
138 , 14